These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37113876)

  • 21. Clinical characteristics and outcome of COVID-19 in patients with rheumatic diseases.
    Alzahrani ZA; Alghamdi KA; Almaqati AS
    Rheumatol Int; 2021 Jun; 41(6):1097-1103. PubMed ID: 33856543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coronavirus Disease Clinical and Laboratory Parameters: Dismembering the Values Reveals Outcomes.
    Zehra T; Siddique SK; Aamir R; Mahmood A; Kiani AH; Virk ST
    Cureus; 2021 Mar; 13(3):e13720. PubMed ID: 33833931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'.
    D'Silva KM; Serling-Boyd N; Wallwork R; Hsu T; Fu X; Gravallese EM; Choi HK; Sparks JA; Wallace ZS
    Ann Rheum Dis; 2020 Sep; 79(9):1156-1162. PubMed ID: 32457048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk stratification of hospital admissions for COVID-19 pneumonia by chest radiographic scoring in a Johannesburg tertiary hospital.
    Labuschagne HC; Venturas J; Moodley H
    S Afr Med J; 2023 Feb; 113(2):75-83. PubMed ID: 36757072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): a structured summary of a study protocol.
    Marietta M; Vandelli P; Mighali P; Vicini R; Coluccio V; D'Amico R;
    Trials; 2020 Jun; 21(1):574. PubMed ID: 32586394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of COVID-19 in Inflammatory Rheumatic Diseases: A Retrospective Cohort Study.
    Alhowaish TS; Alhamadh MS; Alhabeeb AY; Aldosari SF; Masuadi E; Alrashid A
    Cureus; 2022 Jun; 14(6):e26343. PubMed ID: 35903564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
    Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
    Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Factors in COVID-19 Patients With New Neurological Manifestations: A Retrospective Cohort Study in a Romanian Neurology Department.
    Davidescu EI; Odajiu I; Tulbǎ D; Sandu CD; Bunea T; Sandu G; Mureşanu DF; Bǎlǎnescu P; Popescu BO
    Front Aging Neurosci; 2021; 13():645611. PubMed ID: 34220483
    [No Abstract]   [Full Text] [Related]  

  • 29. Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis.
    Wang Q; Liu J; Shao R; Han X; Su C; Lu W
    Rheumatol Int; 2021 May; 41(5):851-861. PubMed ID: 33687528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical course and seroprevalence of COVID-19 in children with rheumatic diseases-cross-sectional study from a reference centre in Spain.
    Udaondo C; Millán-Longo C; Permuy C; Valladares L; Falces-Romero I; Muñoz-Gómez C; Morales-Higuera M; Alcobendas R; Remesal A; Murias S; Calvo C
    Clin Rheumatol; 2022 Jun; 41(6):1779-1784. PubMed ID: 35489011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for hospital admissions related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases.
    Freites Nuñez DD; Leon L; Mucientes A; Rodriguez-Rodriguez L; Font Urgelles J; Madrid García A; Colomer JI; Jover JA; Fernandez-Gutierrez B; Abasolo L
    Ann Rheum Dis; 2020 Nov; 79(11):1393-1399. PubMed ID: 32769150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Prospective Study Evaluating Cumulative Incidence and a Specific Prediction Rule in Pulmonary Embolism in COVID-19.
    Suarez Castillejo C; Toledo-Pons N; Calvo N; Ramon-Clar L; Martínez J; Hermoso de Mendoza S; Morell-García D; Bauça JM; Berga F; Núñez B; Preda L; Sauleda J; Argente Castillo P; Ballesteros A; Martín L; Sala-Llinas E; Alonso-Fernández A
    Front Med (Lausanne); 2022; 9():936816. PubMed ID: 35847817
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes of COVID-19 patients with rheumatic diseases: a retrospective cohort study and synthesis analysis in Wuhan, China.
    Qi G; Wang H; Guo Y; Peng C; Zhang C; Chen T; He J; Jin Z
    Clin Rheumatol; 2022 Jun; 41(6):1899-1910. PubMed ID: 35171364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implications of SARS-CoV-2 infection on the clinical, hematological, and inflammatory parameters in COVID-19 patients: A retrospective cross-sectional study.
    Damiati LA; Bahlas S; Aljohaney A; Bawazir Y; Mustafa M; Denetiu I; Pushparaj PN
    J Infect Public Health; 2022 Feb; 15(2):214-221. PubMed ID: 35007842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between COVID-19 Outcomes and Patient Characteristics: A Study in an Inner-City Community Hospital.
    Almonte M; Au XY; Ali M; Rajabalee N; Hasan S; Shibre T; Li Y; Kaplan AC
    Cureus; 2021 Aug; 13(8):e17255. PubMed ID: 34540480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brixia Chest X-ray Severity Scoring System is in Relation with C-reactive Protein and D-dimer Values in Patients with COVID-19.
    Sofic A; Cizmic M; Beslagic E; Becirevic M; Mujakovic A; Husic-Selimovic A; Granov LA
    Mater Sociomed; 2022 Jun; 34(2):95-99. PubMed ID: 36199845
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19 in Patients with Rheumatic Disease Using Immunomodulatory Drugs: Imaging Findings and Predictors of Hospitalization.
    Azizi H; Karimi H; Kazemi M; Rezaei SS; Parsaei A; Aghaali M; Vafaeimanesh J; Torabi P; Amini B; Masoumi M
    Rheumatol Ther; 2023 Feb; 10(1):249-259. PubMed ID: 36475037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.